<DOC>
	<DOC>NCT01013350</DOC>
	<brief_summary>Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients who Have Participated in Cladribine Clinical Trials</brief_summary>
	<brief_title>Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Trials</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Cladribine</mesh_term>
	<criteria>Prior enrollment into selected oral cladribine clinical trials as of randomization to either study drug or placebo, once participation in the clinical trial has ended Written informed consent was given Subjects who cannot be reached by telephone Subjects unable to answer the registry questionnaires and who do not have a next of kin or caregiver able to answer the registry questionnaires Subjects who either during the lag interval or subsequently enter an interventional study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Cladribine</keyword>
	<keyword>PREMIERE</keyword>
	<keyword>Observational study</keyword>
</DOC>